There are currently about 21 million Americans who are suffering from diabetes, and there are another 41 million Americans who don?t even know they have diabetes. That?s roughly 62,000,000 people altogether, but some could argue that there are close to 200 million people in America who have diabetes.
Diabetes is becoming the focal point by many medical groups and quickly becoming the #1 killer in America. Stemming from Diabetes, 65% will develop Peripheral Neuropathy (damage of the nervous system) and a large and growing number of people looking for a treatment and solution.
EKO International (EKNL) with Neurovasc Medical has a 2 stage process to identify and treat this life threatening condition. EKNL?s JV partner Neurovasc are already in 100 Walmart stores with Neurometrix?s? (NURO:NASDAQ) NC-Stat testing device for Neuropathy. Then once Neuropathy is identified, the patient is referred to many of EKNL referral Clinics and treated using their FDA approved FREMS equipment.
Recently attended medical conference in London, ON definitely showed a lot of interest by many medical group, and even the company hinting to key contracts as we expect will be unleashed as early as this week. This is a major milestone for EKNL and JV company Neurovasc moving solid into the revenue generation phase of a large market and getting bigger.
The potential for EKNL is massive and we will definitely be focusing 100% on the potential of EKNL for the entire month of November!
Smart buyers were definitely scooping up super cheap shares last week on a low volume pull back. We have seen it several times before just prior to a MAJOR bullish breakout and? EKNL is sitting at prime ?buy? levels. With MAJOR contracts expected to be unleashed this week, we can see prices move super quick and into multi-dollar level.
EKNL continues to hold on to over 1,500% gains for 6 weeks now, proving how solid EKNL?is and that there is absolutely zero dilution. In fact with the share buy back program in effect, more shares are falling into super strong hands as share inventory continues to dry up. With an active float of 5.5 Million shares confirmed by the company, expect this figure to be reduced further as the company continues to buy back shares in the open market.
With MONSTER news continuing to be unleashed by the company we are on HIGH news watch for more market shaking updates that will propel prices sky high including MAJOR contracts to be unleashed from the 13th annual Medical conference last weekend.
With expected flurry of contracts to be released and key updates this week, investors do not want to miss this action and potential for MONSTER gains ? we will definitely be front and center again adding to our position and bringing you the updates and gains!.
Key points that make EKNL a solid long term play for MEGA gains:
1) No dilution or insiders selling any time soon and especially at these super low prices. In fact, this leads to our second key similarity
?Upon the achievement of a positive income statement and the repayment of its liabilities, the Company intends to initiate a program to buy-back common shares on the open market.?
?
2) Share buyback in effect. Definitely the goal here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.
3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL?s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT.
ABOUT EKO INTERNATIONAL
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company? is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
Join our exclusive Room and Live CHAT on douknow.com by clicking here
Also, join us at our new investors hangout board at http://investorshangout.com/
Compensation: Ourhotstockpicks has not been compensated for the profile of EKNL.
Ourhotstockpicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale.? An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Ourhotstockpicks may be buyers of features in the open market. Click here to view the full disclaimer
from your own site.
matt barkley melanie amaro x factor boise state jordans prometheus movie posterior adam lambert arrested
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন